Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
(NASDAQ: ZYME) Delayed: 23.26 +0.12 (0.52%)
Previous Close $23.14    52 Week High $ 
Open $23.51    52 Week Low $ 
Day High $23.62    P/E N/A 
Day Low $23.05    EPS $ 
Volume 530,631